Technical Analysis for MYOK - MyoKardia, Inc.

Grade Last Price % Change Price Change
grade C 99.24 -2.39% -2.43
MYOK closed down 2.39 percent on Friday, August 14, 2020, on 49 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down
Historical MYOK trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Multiple of Ten Bearish Other 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.39%
Multiple of Ten Bullish Other -2.39%
Inside Day Range Contraction -2.39%
Overbought Stochastic Strength -2.39%
Stochastic Sell Signal Bearish -2.25%
20 DMA Support Bullish -2.25%
50 DMA Support Bullish -2.25%
180 Bullish Setup Bullish Swing Setup -2.25%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

MyoKardia, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for the treatment of serious and neglected rare cardiovascular diseases. Its lead product candidate is MYK-461, a small molecule that is in three Phase I clinical trials designed to reduce excessive cardiac muscle contractility leading to hypertrophic cardiomyopathy (HCM). The company also develops DCM-1, a product candidate that treats heritable dilated cardiomyopathy (DCM) by restoring normal contractility in the diseased DCM heart. In addition, it develops HCM-2, a product candidate to reduce cardiac muscle contractility to normal levels in HCM patients; and LUS-1, a product candidate, which is intended to counteract a muscle disruption that results in impaired relaxation of the heart. MyoKardia, Inc. has a strategic collaboration with Sanofi S.A. The company was founded in 2012 and is headquartered in South San Francisco, California.
Anatomy Sports Medicine Cardiomyopathy Muscular System

Is MYOK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 126.3
52 Week Low 42.65
Average Volume 424,242
200-Day Moving Average 75.06
50-Day Moving Average 96.80
20-Day Moving Average 97.22
10-Day Moving Average 100.61
Average True Range 4.30
ADX 14.44
+DI 20.88
-DI 21.02
Chandelier Exit (Long, 3 ATRs ) 92.49
Chandelier Exit (Short, 3 ATRs ) 101.65
Upper Bollinger Band 105.11
Lower Bollinger Band 89.32
Percent B (%b) 0.63
BandWidth 16.24
MACD Line 1.81
MACD Signal Line 1.33
MACD Histogram 0.4782
Fundamentals Value
Market Cap 3.12 Billion
Num Shares 31.5 Million
EPS -0.65
Price-to-Earnings (P/E) Ratio -152.68
Price-to-Sales 26.88
Price-to-Book 9.37
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 103.67
Resistance 3 (R3) 103.95 102.76 102.93
Resistance 2 (R2) 102.76 101.63 102.62 102.68
Resistance 1 (R1) 101.00 100.94 100.41 100.72 102.44
Pivot Point 99.81 99.81 99.51 99.67 99.81
Support 1 (S1) 98.05 98.68 97.46 97.77 96.04
Support 2 (S2) 96.86 97.99 96.72 95.80
Support 3 (S3) 95.10 96.86 95.55
Support 4 (S4) 94.82